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ABSTRACT
Objectives To quantify the variation in rates of
absence due to musculoskeletal pain across 47
occupational groups (mostly nurses and ofﬁce workers)
from 18 countries, and to explore personal and group-
level risk factors that might explain observed differences.
Methods A standardised questionnaire was used to
obtain information about musculoskeletal pain, sickness
absence and possible risk factors in a cross-sectional
survey of 12 416 workers (92–1017 per occupational
group). Additionally, group-level data on socioeconomic
variables, such as sick pay and unemployment rates,
were assembled by members of the study team in each
country. Associations of sickness absence with risk
factors were examined by Poisson regression.
Results Overall, there were more than 30-fold
differences between occupational groups in the 12-
month prevalence of prolonged musculoskeletal sickness
absence, and even among ofﬁce workers carrying out
similar occupational tasks, the variation was more than
tenfold. Personal risk factors included older age, lower
educational level, tendency to somatise, physical loading
at work and prolonged absence for non-musculoskeletal
illness. However, these explained little of the variation
between occupational groups. After adjustment for
individual characteristics, prolonged musculoskeletal
sickness absence was more frequent in groups with
greater time pressure at work, lower job control and
more adverse beliefs about the work-relatedness of
musculoskeletal disorders.
Conclusions Musculoskeletal sickness absence might
be reduced by eliminating excessive time pressures in
work, maximising employees’ responsibility and control
and providing ﬂexibility of duties for those with disabling
symptoms. Care should be taken not to overstate work
as a cause of musculoskeletal injury.
INTRODUCTION
Absence from work because of sickness is disrup-
tive and expensive. For example, the annual cost to
the national economy of the UK has been estimated
at around £15 billion.1 In most countries, the ﬁnan-
cial burden falls mainly on employers and/or the
social security system, but sickness absence also
impacts on the earnings of employees, and even
where their income is protected, it can be dam-
aging to their conﬁdence and self-esteem.
While attributed ostensibly to ill health or injury,
sickness absence is also inﬂuenced by the
personality and attitudes of the worker,2–4 the
physical and psychological demands of their job,5–
13 social and cultural norms,3 14 15 and ﬁnancial
circumstances, such as availability and levels of sick
pay and social security beneﬁts.3 15–19 Some of
these factors vary by country and employer, and
may be amenable to modiﬁcation. Thus, if there
were major differences in rates of sickness absence
between workforces in different countries, and
especially those carrying out similar types of work,
identiﬁcation of the causes might provide valuable
pointers to practical preventive policies.
Attempts to compare levels of sickness absence
between countries have been complicated by differ-
ences in the methods by which routine national sta-
tistics are compiled.20 21 A few studies have
circumvented this problem by using other, more
uniform methods of data collection,11 20–22 and
some have suggested substantial variation in rates
of absence.20–22 However, their design has not
allowed detailed exploration of the reasons for the
observed differences.
We present here, an analysis of data on sickness
absence from the CUPID (Cultural and
Psychosocial Inﬂuences on Disability) study, which
used standardised methods to collect information
on 47 occupational groups in 18 countries.23 The
study focused on disability from musculoskeletal
complaints, which in many countries are the major
reason given for longer-term sickness absence.24–26
The aims of our analysis were to quantify the vari-
ation in rates of absence for musculoskeletal pro-
blems between occupational groups, and to explore
factors that might underlie observed differences.
METHODS
The 47 occupational groups that we studied (table 1)
fell into three broad categories—nurses (including
nursing assistants), ofﬁce workers and ‘other
workers’ (mainly manual workers who carried out
repetitive tasks with their hands or arms).
Data collection was carried out during 2006–
2011, by teams of local investigators in each
country, who identiﬁed populations suitable for
study, and recruited participants from these popula-
tions. Each participant was asked to complete a
questionnaire, either at interview or by self-
administration. The method of answering the ques-
tionnaire depended on considerations, such as the
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literacy of participants, their geographical dispersion and the
willingness of employers to allow employee time for interviews.
Only one method was used for each occupational group, except
in the UK, where most questionnaires were self-administered,
but random samples of each occupational group were inter-
viewed, and in South Africa, where most nurses were inter-
viewed, but a few answered by self-administration.
The questionnaire was originally developed in English and
then translated into local languages as necessary. The accuracy
of translation was checked by independent back-translation, fol-
lowing which, amendments were made if required. Among
other things, the questionnaire asked about demographic charac-
teristics, age at which full-time education was completed,
current occupation, pain during the past 12 months in each of
six anatomical regions (low back, neck, shoulder, elbow, wrist/
hand and knee) as depicted in diagrams, fear-avoidance beliefs
concerning low back and upper limb pain, distress from
common somatic symptoms, mental health and total duration of
Table 1 Occupational groups included in the CUPID study
Country Occupational group Response rate (%) Number of participants analysed
Brazil (BR) Nurses 96 184
Office workers 97 278
Other workers (sugarcane cutters) 61 93
Ecuador (EC) Nurses 99 219
Office workers 100 243
Other workers (flower plantation) 99 227
Colombia (CO) Office workers 89 92
Costa Rica (CR) Nurses 91 220
Office workers 91 223
Other workers (telephone call centre) 94 205
Nicaragua (NI) Nurses 100 282
Office workers 100 285
Other workers (machine operators) 100 197
UK (UK) Nurses 42 256
Office workers 45 380
Other workers (mail sorters) 28 386
Spain (SP) Nurses 96 667
Office workers 98 438
Italy (IT) Nurses 76 536
Other workers (assembly line) 52 136
Greece (GR) Nurses 93 224
Office workers 99 199
Other workers (postal clerks) 91 140
Estonia (EE) Nurses 48 370
Office workers 53 202
Lebanon (LB) Nurses 96 184
Office workers 86 172
Other workers (food production) 98 137
Iran (IR) Nurses 94 246
Office workers 88 182
Pakistan (PK) Nurses 94 187
Office workers 100 180
Other workers (mail sorters) 96 222
Sri Lanka (LK) Nurses 95 236
Office workers 63 152
Other workers-1 (mail sorters) 100 250
Other workers-2 (sewing machinists) 86 151
Japan ( JP) Nurses 76 592
Office workers 81 310
Other workers-1 (transportation operatives) 86 1017
Other workers-2 (sales workers) 98 355
South Africa (SA) Nurses 90 247
Office workers 83 229
Australia (AU) Nurses 39 250
New Zealand (NZ) Nurses 70 177
Office workers 52 145
Other workers (mail sorters) 50 113
CUPID, Cultural and Psychosocial Influences on Disability.
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sickness absence in the past 12 months (0, 1–5, 6–30 and
>30 days) because of pain in each of the six speciﬁed anatom-
ical regions, and because of other illness.
The questions about current occupation covered working
hours, whether an average working day involved various speci-
ﬁed physical activities, time pressures at work and job control,
support, satisfaction and security. Exposure to physical loading
at work was scored according to how many of ﬁve activities
(lifting weights of 25 kg or more by hand, working for longer
than 1 h in total with the hands above shoulder height, repeated
bending and straightening of the elbow for longer than 1 h in
total, use of a computer keyboard or other repeated movements
of the wrist or ﬁngers for longer than 4 h in total, and kneeling
or squatting for longer than 1 h in total) were reported in an
average working day. Time pressure at work was considered to
be present if a participant reported either a target number of
articles or tasks to be ﬁnished in the working day, or working
under pressure to complete tasks by a ﬁxed time; lack of
support at work if help with difﬁculties was seldom or never
provided by colleagues or a supervisor/manager; job dissatisfac-
tion if overall, the participant felt dissatisﬁed or very dissatisﬁed
with their employment; lack of control if there was seldom or
never any choice in all of: a) how work was done, b) what was
done at work, and c) work timetable and breaks; and job inse-
curity if the participant felt that the tenure of their employment
would be ‘rather unsafe’ or ‘very unsafe’ if they were off work
for 3 months with signiﬁcant illness.
Questions regarding fear-avoidance beliefs were adapted from
the Fear Avoidance Beliefs Questionnaire.27 Participants were
deemed to have adverse beliefs about:
▸ The work-relatedness of musculoskeletal pain, if they com-
pletely agreed that either low back pain or arm pain (includ-
ing pain in the shoulder or hands) is commonly caused by
people’s work.
▸ Physical activity, if either for someone with low back pain, or
for someone with arm pain, they completely agreed both
that physical activity should be avoided as it might cause
harm, and that rest was needed to get better.
▸ Prognosis, if either for someone with low back pain or for
someone with arm pain, they completely agreed that neglect-
ing such problems can cause permanent health problems,
and completely disagreed that such problems usually get
better within 3 months.
Questions about distress from somatic symptoms were taken
from the Brief Symptom Inventory,28 and somatising tendency
was graded according to the number of symptoms from a total
of ﬁve (faintness or dizziness, pains in the heart or chest, nausea
or upset stomach, trouble getting breath, and hot or cold spells)
that had been at least moderately distressing in the past week.
Questions on mental health were taken from the Short Form-36
(SF-36) questionnaire,29 and scores were grouped to approxi-
mate thirds of the distribution in the combined study sample
(denoted good, intermediate or poor mental health).
Data from the questionnaires were entered into a computer
by local investigators, and after checks for errors, were transmit-
ted to the coordinating centre in Southampton for collation and
analysis.
In addition to the data on individual study participants, local
investigators provided standardised information about the
employment and socioeconomic circumstances of the occupa-
tional groups which they had recruited. This included the local
unemployment rate at the time of the survey, entitlement to sick
pay in the ﬁrst 3 months of absence, availability of social secur-
ity support for the unemployed, ﬁnancial support for ill health
retirement, whether a fee was payable for primary medical care
and entitlement to compensation for work-related musculoskel-
etal disorders.
Further details of the methods of data collection and charac-
teristics of occupational groups have been published
elsewhere.23
Analysis was carried out with Stata V.12.1 software, and as
speciﬁed in the original protocol, was restricted to subjects
aged 20–59 years who had worked in their job for at least
12 months. The main outcome analysed was prolonged sick-
ness absence during the past 12 months because of musculo-
skeletal pain. This was deﬁned to have occurred where, for at
least one of the six anatomical regions listed in the question-
naire, the participant reported absence for >5 days in total
during the past 12 months because of pain. We ﬁrst assessed
the extent to which this outcome varied by occupational group
as compared with prolonged absence (>5 days in total) for
other illness.
Next, we explored associations of prolonged musculoskeletal
sickness absence with personal characteristics that might contrib-
ute to differences in prevalence between occupational groups.
For this, we used GLLAMM (generalised linear latent and
mixed models) to ﬁt two-level random-effects Poisson regression
models with robust SEs,30 in which individuals were clustered
by occupational group. Associations were summarised by preva-
lence rate ratios (PRRs) with associated 95% CIs. From a ﬁnal
regression model including all the personal characteristics exam-
ined, we calculated the expected numbers of workers with pro-
longed musculoskeletal absence in each occupational group.
Each individual’s relative risk of prolonged absence was derived
from the modelled risk estimates for the combination of risk
factors to which he/she was exposed. The individual’s probabil-
ity of being a case was then calculated as the product of his/her
relative risk, and a constant which was set such that the total
expected number of cases across all participants in the study
equalled the total number of cases observed. Finally, probabil-
ities were summed across all individuals in an occupational
group to give its expected number of cases.
The natural logarithms of these expected numbers were then
used as an offset in Poisson regression analyses (with robust esti-
mates of variance), taking the 47 occupational groups as the
units of analysis, to explore the associations of prolonged mus-
culoskeletal absence with risk factors acting at occupational
group level. As well as the information on employment and
socioeconomic circumstances that was provided by the local
investigators, we analysed group-level risk factors that were
deﬁned by the prevalence of speciﬁed individual characteristics
within each group. These prevalence rates were treated as con-
tinuous variables, and risks were estimated for 1 SD increase in
each.
Next, we explored the extent to which personal and group-
level risk factors might explain differences in the prevalence of
prolonged musculoskeletal absence between occupational
groups. For each group, we calculated the ratios of the observed
prevalence of absence to that which would have been expected
with no allowance for risk factors, with allowance for personal
risk factors and with allowance for both personal and group-
level risk factors. We then summarised the dispersions of these
ratios across the 47 occupational groups by dot plots and geo-
metric SDs (for this purpose the ratio in one occupational
group with no observed cases was taken as 0.1).
Finally, to check for possible bias, we repeated analyses,
excluding the ﬁve occupational groups in which the participa-
tion rate was <50% (identiﬁed in table 1).
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RESULTS
Response rates among those invited to take part in the study were
higher than 80% in 33 of the 47 occupational groups studied, and
lower than 50% in only ﬁve groups (table 1). After elimination of
subjects who did not meet the inclusion criteria that had been spe-
ciﬁed in the protocol (age 20–59 years, worked in current job for
at least 12 months), and a further 317 for whom critical informa-
tion was missing (eg, on sex or age), the CUPID study sample com-
prised a total of 12 426 participants. Further details of exclusions
and the characteristics of the study sample have been reported else-
where.23 For the purposes of this report, we excluded an add-
itional 10 participants with missing information on sickness
absence for musculoskeletal pain. Thus, analysis was based on
12 416 subjects (4348 men and 8068 women).
Figure 1 shows the 12-month prevalence of prolonged sick-
ness absence for musculoskeletal pain and for other illness by
occupational group. There was substantial variation, even
between occupational groups within the same category. Thus,
among ofﬁce workers, the rate of prolonged absence for muscu-
loskeletal pain ranged from 0% (95% CI 0% to 2%) in Pakistan
to 13% (95% CI 9% to 18%) in South Africa, and in nurses,
from 1% (95% CI 1% to 3%) in Japan to 29% (95% CI 23%
to 36%) in Costa Rica. Among the other workers, the lowest
prevalence of prolonged absence for musculoskeletal pain was
in sales/marketing personnel in Japan (0.8%, 95% CI 0.2% to
2%), and the highest in production workers at a factory making
pushchairs in Italy (34%, 95% CI 26% to 42%). Rates of pro-
longed absence for musculoskeletal pain tended to correlate
with those for other illness (Spearman correlation coefﬁ-
cient=0.55), but nurses reported relatively more absence
because of musculoskeletal pain than ofﬁce workers.
Table 2 summarises the relationship of prolonged sickness
absence for musculoskeletal pain to personal characteristics.
Findings are presented from three Poisson regression models. In
Model 1, which included all the risk factors other than non-
musculoskeletal absence and number of painful anatomical sites,
there were strong associations with exposure to physical
loading, older age, somatising tendency and poor mental health.
Additionally, risk was elevated in workers, with adverse beliefs
about the work-relatedness and prognosis of musculoskeletal
pain, and tended to be higher in those with lower levels of edu-
cation. Among the psychosocial aspects of work that were
examined, the strongest associations were with time pressure at
work and job dissatisfaction.
Addition of prolonged absence for non-musculoskeletal illness
(Model 2) had minimal impact on the risk estimates for other vari-
ables, although such absence was itself an important risk factor
(PRR 1.54, 95% CI 1.22 to 1.95). When number of painful ana-
tomical sites was also included (Model 3), many of the risk esti-
mates were reduced. However, signiﬁcant associations remained
with older age, somatising tendency, poor mental health, time
pressure at work, adverse beliefs about the prognosis of musculo-
skeletal disorders and prolonged absence in the past 12 months
for non-musculoskeletal illness.
Table 3 shows associations with risk factors acting at the level
of the occupational group, after allowance for all the personal
characteristics that were examined in table 2. When the group-
level risk factors were analysed independently (Model 4), signiﬁ-
cant associations were found with lower group prevalence of
adverse beliefs about musculoskeletal pain and physical activity,
and higher group prevalence of reported time-pressure at work,
lack of job control, and prolonged sickness absence for non-
musculoskeletal reasons. When effects were mutually adjusted in
a single model that excluded only prevalence of non-
musculoskeletal absence (Model 5), additional associations
emerged with higher group prevalence of adverse beliefs about
the work-relatedness of musculoskeletal pain, and lower group
prevalence of perceived job insecurity.
With adjustment also for group prevalence of prolonged
absence for non-musculoskeletal reasons (Model 6), the associa-
tions with group prevalence of low job control and of job inse-
curity lost their signiﬁcance. However, signiﬁcant associations
remained with group prevalence of adverse beliefs about the
work-relatedness of musculoskeletal pain (PRR for 1 SD
increase in prevalence 1.22, 95% CI 1.01 to 1.47), adverse
beliefs about musculoskeletal pain and physical activity (PRR
0.68, 95% CI 0.53 to 0.85), time pressure at work (PRR 1.43,
95% CI 1.24 to 1.65) and absence in the past 12 months for
non-musculoskeletal reasons (PRR 1.34, 95% CI 1.16 to 1.56).
Neither Model 5 nor Model 6 suggested any importantly higher
risk when full sick pay was provided during the ﬁrst 3 months
of absence, or when compensation was available for work-
related musculoskeletal disorders.
Figure 2 shows the ratios of observed to expected 12-month
prevalence of prolonged absence because of musculoskeletal dis-
orders by occupational group, when expected numbers of cases
were calculated with and without allowance for different risk
factors. With increasing adjustment, the variation in ratios of
observed to expected prevalence reduced but was still substantial
(geometric SDs 2.5 with no adjustment, 2.1 with adjustment for
personal risk factors, and 1.8 after adjustment also for group-
level risk factors). The groups with the lowest ratios of observed
to expected were ofﬁce workers in Pakistan (ratio=0) and
Estonia (0.17), while the highest ratios were in ofﬁce workers
from Colombia (3.6) and sugarcane cutters from Brazil (3.3).
When analyses were repeated with exclusion of the ﬁve occu-
pational groups in which the participation rate was <50%,
results were not materially altered.
DISCUSSION
Among the 47 occupational groups that we studied, there were
more than 30-fold differences in the prevalence of prolonged
Figure 1 Twelve-month prevalence of prolonged sickness absence
(>5 days in total) for musculoskeletal pain and for other illness by
occupational group.
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sickness absence attributed to musculoskeletal pain, and even
for ofﬁce workers carrying out similar occupational tasks, the
variation was more than tenfold. Risk factors for such absence
included older age, lower educational level, tendency to soma-
tise, physical demands of work and prolonged sickness absence
for non-musculoskeletal illness. Together, however, these
Table 2 Associations of personal characteristics with prolonged sickness absence (> 5 days in total) in past 12 months because of
musculoskeletal pain
Cases* Model 1† Model 2† Model 3†
Risk factor Number in sample N (%) PRR (95% CI) PRR (95% CI) PRR (95% CI)
Sex
Male 4348 235 (5.4) 1 1 1
Female 8068 705 (8.7) 1.17 (1.00 to 1.37) 1.18 (1.01 to 1.38) 1.02 (0.88 to 1.19)
Age (years)
20–29 3058 139 (4.5) 1 1 1
30–39 3971 283 (7.1) 1.51 (1.18 to 1.94) 1.50 (1.16 to 1.93) 1.35 (1.06 to 1.73)
40–49 3451 308 (8.9) 1.74 (1.35 to 2.23) 1.72 (1.33 to 2.23) 1.38 (1.08 to 1.77)
50–59 1936 210 (10.8) 2.13 (1.72 to 2.63) 2.08 (1.67 to 2.60) 1.60 (1.29 to 1.98)
Age finished full-time education (years)
≥20 7244 486 (6.7) 1 1 1
17–19 3374 263 (7.8) 1.18 (0.98 to 1.42) 1.17 (0.97 to 1.41) 1.15 (0.96 to 1.38)
14–16 1269 130 (10.2) 1.29 (0.99 to 1.68) 1.27 (0.97 to 1.65) 1.28 (1.00 to 1.65)
<14 470 57 (12.1) 1.35 (0.90 to 2.02) 1.33 (0.90 to 1.97) 1.21 (0.82 to 1.78)
Unknown 59 4 (6.8) 0.79 (0.28 to 2.19) 0.80 (0.30 to 2.16) 0.97 (0.36 to 2.56)
Number of distressing somatic symptoms in past week
0 7399 392 (5.3) 1 1 1
1 2609 212 (8.1) 1.23 (1.05 to 1.45) 1.22 (1.04 to 1.43) 1.09 (0.93 to 1.27)
2+ 2286 318 (13.9) 1.69 (1.46 to 1.97) 1.62 (1.39 to 1.89) 1.24 (1.08 to 1.44)
Missing 122 18 (14.8) 1.30 (0.86 to 1.97) 1.29 (0.85 to 1.94) 1.17 (0.76 to 1.81)
Mental health
Good 4700 295 (6.3) 1 1 1
Intermediate 3756 269 (7.2) 1.14 (0.98 to 1.32) 1.13 (0.98 to 1.31) 1.06 (0.92 to 1.22)
Poor 3885 366 (9.4) 1.39 (1.21 to 1.60) 1.36 (1.19 to 1.57) 1.19 (1.04 to 1.35)
Missing 75 10 (13.3) 1.75 (0.83 to 3.68) 1.85 (0.89 to 3.82) 1.63 (0.76 to 3.52)
Number of physically loading activities
0 874 35 (4.0) 1 1 1
1 2198 94 (4.3) 1.11 (0.77 to 1.58) 1.11 (0.78 to 1.58) 0.99 (0.70 to 1.40)
2 3711 253 (6.8) 1.37 (0.94 to 1.99) 1.37 (0.94 to 1.98) 1.16 (0.78 to 1.71)
3 3068 286 (9.3) 1.71 (1.20 to 2.44) 1.72 (1.21 to 2.44) 1.38 (0.96 to 1.99)
4 1750 165 (9.4) 1.69 (1.18 to 2.41) 1.68 (1.18 to 2.40) 1.30 (0.90 to 1.88)
5 815 107 (13.1) 2.09 (1.44 to 3.03) 2.10 (1.45 to 3.02) 1.49 (1.02 to 2.18)
Psychosocial aspects of work
Work >50 hours per week 2664 106 (4.0) 0.84 (0.65 to 1.09) 0.84 (0.65 to 1.09) 0.90 (0.69 to 1.17)
Time pressure at work 9341 785 (8.4) 1.27 (1.06 to 1.52) 1.27 (1.06 to 1.52) 1.23 (1.03 to 1.46)
Lack of support at work 3013 296 (9.8) 1.08 (0.93 to 1.25) 1.09 (0.94 to 1.25) 1.03 (0.89 to 1.18)
Job dissatisfaction 2535 223 (8.8) 1.22 (1.05 to 1.42) 1.22 (1.04 to 1.41) 1.10 (0.95 to 1.27)
Lack of job control 2663 250 (9.4) 1.06 (0.95 to 1.18) 1.05 (0.94 to 1.17) 1.04 (0.94 to 1.16)
Job insecurity 3912 277 (7.1) 0.90 (0.79 to 1.03) 0.91 (0.79 to 1.04) 0.89 (0.78 to 1.02)
Adverse beliefs about musculoskeletal pain
Work-relatedness 4870 470 (9.7) 1.24 (1.10 to 1.39) 1.23 (1.09 to 1.38) 1.10 (0.98 to 1.24)
Physical activity 2576 219 (8.5) 1.14 (0.97 to 1.33) 1.13 (0.97 to 1.33) 1.18 (1.02 to 1.37)
Prognosis 2079 240 (11.5) 1.40 (1.19 to 1.65) 1.38 (1.17 to 1.62) 1.23 (1.06 to 1.44)
>5 days absence in past 12 months for other illness 1226 194 (15.8) 1.54 (1.22 to 1.95) 1.43 (1.16 to 1.77)
Number of anatomical sites painful for ≥7 days in past 12 months
0–1 7765 274 (3.5) 1
2 1530 138 (9.0) 2.16 (1.78 to 2.62)
3 1468 170 (11.6) 2.67 (2.21 to 3.22)
4 975 159 (16.3) 3.40 (2.86 to 4.03)
5 462 129 (27.9) 4.55 (3.78 to 5.48)
6 216 70 (32.4) 4.98 (3.85 to 6.44)
*Number (%) of cases among those exposed to risk factor.
†Risk estimates derived from a single Poisson regression model incorporating all variables for which results are presented.
PRR, prevalence rate ratio.
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Table 3 Associations of group-level risk factors with prolonged sickness absence (>5 days in total) in past 12 months because of musculoskeletal disorders
Risk factor
Number of occupational
groups exposed
Level of
exposure Model 4* Model 5† Model 6†
Mean (SD‡) PRR (95% CI) PRR (95% CI) PRR (95% CI)
Unemployment rate ≥10% 12 1.05 (0.74 to 1.48) 0.98 (0.61 to 1.57) 1.04 (0.70 to 1.54)
Full sick pay in first three months absence 25 1.11 (0.80 to 1.54) 1.07 (0.72 to 1.59) 1.06 (0.74 to 1.52)
Social security for long-term unemployment 28 1.28 (0.94 to 1.75) 0.80 (0.47 to 1.37) 0.87 (0.48 to 1.58)
Financial support for ill-health retirement (sometimes or usually) 28 1.31 (0.90 to 1.89) 1.33 (0.87 to 2.01) 0.98 (0.65 to 1.46)
Payment for primary care (part or full) 19 0.91 (0.66 to 1.26) 1.02 (0.65 to 1.61) 1.09 (0.69 to 1.71)
Compensation for work-related musculoskeletal disorders (any) 38 1.27 (0.92 to 1.75) 1.11 (0.73 to 1.70) 1.08 (0.77 to 1.51)
Group prevalence (%) of adverse beliefs about work-relatedness of musculoskeletal pain§ 47 39 21 0.93 (0.82 to 1.06) 1.24 (1.04 to 1.48) 1.22 (1.01 to 1.47)
Group prevalence (%) of adverse beliefs about musculoskeletal pain and physical activity§ 47 22 19 0.84 (0.71 to 0.99) 0.62 (0.48 to 0.81) 0.68 (0.53 to 0.85)
Group prevalence (%) of adverse beliefs about prognosis of musculoskeletal pain§ 47 16 9 1.02 (0.88 to 1.18) 1.02 (0.85 to 1.22) 1.03 (0.86 to 1.23)
Group prevalence (%) of time pressure at work§ 47 77 16 1.33 (1.14 to 1.56) 1.54 (1.30 to 1.82) 1.43 (1.24 to 1.65)
Group prevalence (%) of lack of support at work§ 47 22 20 1.03 (0.93 to 1.15) 1.04 (0.92 to 1.17) 1.06 (0.93 to 1.22)
Group prevalence (%) of job dissatisfaction§ 47 17 16 0.95 (0.76 to 1.20) 1.10 (0.91 to 1.33) 1.05 (0.84 to 1.32)
Group prevalence (%) of lack of job control§ 47 22 20 1.20 (1.03 to 1.40) 1.28 (1.12 to 1.47) 1.08 (0.90 to 1.28)
Group prevalence (%) of job insecurity§ 47 31 18 0.91 (0.74 to 1.11) 0.79 (0.67 to 0.93) 0.94 (0.78 to 1.13)
Group prevalence (%) of >5days absence in past 12 months for other illness§ 47 10 6 1.45 (1.28 to 1.64) 1.34 (1.16 to 1.56)
Analysis was based on 47 occupational groups.
*Each risk factor analysed independently in a separate Poisson regression model.
†Mutually adjusted risk estimates derived from a single Poisson regression model incorporating all the risk factors for which results are presented.
‡Mean and SD of prevalence (%) across the 47 occupational groups.
§Analysed as a continuous variable. Risk estimates are for an increase of one SD.
PRR, prevalence rate ratio.
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personal characteristics explained little of the disparity between
occupational groups. After adjustment for personal characteris-
tics, features of occupational groups that carried a higher risk of
prolonged musculoskeletal absence included a higher prevalence
of time pressure at work, and of prolonged sickness absence for
non-musculoskeletal illness. However, the provision of sick pay
and availability of compensation for work-related musculoskel-
etal disorders had no discernible impact.
Our investigation had the advantage of standardised data col-
lection on large numbers of workers from multiple occupational
groups in culturally diverse settings. Moreover, unlike most pre-
vious studies, it was able to assess simultaneously risk factors
operating both at the level of the individual and of the occupa-
tional group.
It is possible that some workers with serious health problems
were excluded from the study because they had left employ-
ment, or were unavailable when data were collected. This may
have caused rates of prolonged sickness absence to be somewhat
underestimated, but it is highly unlikely that it could account
for differences between occupational groups of the magnitude
that were observed.
We took as our outcome >5 days sickness absence because of
pain in at least one of six anatomical sites, but did not separately
analyse absence ascribed to pain at speciﬁc sites. This was
because while the physical activities that may precipitate, aggra-
vate, or be made difﬁcult by musculoskeletal pain, differ by ana-
tomical site, psychosocial risk factors for pain at different sites
are remarkably similar.31–34 Furthermore, we were concerned
that where participants were absent from work with pain at
multiple sites (eg, neck and shoulder), they would have difﬁculty
in reliably attributing the absence to pain at a single site.
We opted to focus on absence for more than 5 days in total,
because this would be more burdensome for employers than
absence of shorter duration, and was likely to be recalled more
reliably. However, because of the way the questions were
framed, we do not know how often the outcome included a
continuous period of longer than 5 days away from work, and
how frequently it was made up of several spells of absence, each
of shorter duration. Analysis of absence for longer than 30 days
in total during the past year, because of pain at an anatomical
site produced broadly similar results (data not shown).
Like the outcome measures, exposures to potential risk
factors were ascertained by self-report, and this raises the
possibility that responses were biased by factors related to
experience of musculoskeletal disorders. However, it seems
unlikely that such bias could explain the major differences in
prevalence of absence between occupational groups or the
failure of personal risk factors to account for them.
When we began our analysis, we expected the inter-relation of
risk factors to be complex. For example, exposure to stressful
physical activities might increase the incidence of musculoskeletal
disorders and thereby lead to absence, but it could also make it
harder to perform a job when symptoms were present, irrespective
of whether they were caused by work. And at group level, time
pressures at work might have an effect on sickness absence for
many types of illness, but a greater impact on musculoskeletal
absence speciﬁcally. Therefore, to achieve a better understanding,
we compared ﬁndings from statistical models with and without
the inclusion of variables for the number of anatomical sites with
pain and absence for non-musculoskeletal illness.
The associations that we found for prolonged musculoskeletal
absence with older age and lower level of education were con-
sistent with ﬁndings from earlier studies.8 14 15 19 22 35
Similarly, the higher risk when more anatomical sites had been
painful during the past year was unsurprising.
An association of sickness absence with the physical demands
of work has also been reported before.7–13 36 It is possible that
experience of musculoskeletal pain increased participants’
awareness and reporting of physical activities at work. However,
the generally lower rates of musculoskeletal absence in ofﬁce
workers as compared with nurses (a physically more demanding
job) suggest that the association was not due simply to biased
reporting of activities by individuals with pain. That the associ-
ation was still clearly present, albeit somewhat reduced, when
adjustment was made for the number of anatomical sites with
pain, indicates that the relationship did not occur simply
because physical activities triggered musculoskeletal disorders.
Additionally, a need to perform stressful physical activities
makes it more difﬁcult to work when pain is present.
Positive associations were observed with adverse beliefs about
the work-relatedness and prognosis of musculoskeletal pain, and
it is plausible that individuals who believe that musculoskeletal
disorders are caused by work or carry a poor outlook, would be
more likely to take absence when musculoskeletal symptoms
occur. Similarly, adverse beliefs about harm from physical activ-
ity might deter some people from attending work, especially if
their job was physically demanding.
Prolonged musculoskeletal absence was also associated with
somatising tendency and poor mental health. Both these charac-
teristics are known to be associated with, and to predict, muscu-
loskeletal symptoms,31–34 and the substantial reductions in their
risk estimates after adjustment for report of pain (Model 3,
table 2) suggests that their relation to absence is explained
largely by their associations with pain.
Even after allowance for other personal characteristics, pro-
longed musculoskeletal absence was strongly associated with indi-
vidual history of prolonged absence for non-musculoskeletal
reasons. This is likely to reﬂect, at least in part, a greater propen-
sity of some individuals to take sickness absence, which goes
beyond their demographic and occupational characteristics. Such
individual differences in tendency to take sickness absence have
been documented in earlier studies, and have been linked with
various inﬂuences including upbringing and family situation.3 15 37
When exploring determinants of musculoskeletal absence at
the level of occupational groups, we considered not only the
employment conditions and socioeconomic circumstances of
workforces, but also a number of variables deﬁned according to
Figure 2 Ratios of observed to expected prevalence of prolonged
sickness absence in past year (>5 days in total) because of
musculoskeletal pain in 47 occupational groups, according to level of
adjustment for risk factors.
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the prevalence of exposures reported by individual workers in
each occupational group. These exposures had already been
examined as risk factors at individual level, but it was possible
that the perceptions of individual workers and their reporting
of the exposures was inﬂuenced by whether or not they had suf-
fered from musculoskeletal pain sufﬁcient to cause prolonged
sickness absence, and this could have led to bias. A group-level
measure, which took account of reports from workers both
with and without pain would be less prone to such bias.
Furthermore, it was possible that these risk factors contributed
to differences between occupational groups in a way that
exceeded their inﬂuence on which workers within an occupa-
tional group took sickness absence. For example, inclination to
take sickness absence might be inﬂuenced by a culture of
absence within an occupational population, as well as being
related to an individual’s personal history of absence for non-
musculoskeletal illness.
Among the group-level risk factors, two showed associations in
Model 5 which disappeared when prevalence of prolonged non-
musculoskeletal absence was added to form Model 6, suggesting
that they had an effect on sickness absence in general, and not spe-
ciﬁcally from musculoskeletal disorders. These were a higher
prevalence of low job control and a lower prevalence of job inse-
curity. Both these ﬁndings are highly plausible. Low job control
may reduce workers’ scope to modify their activities in response to
health problems, as well as making their job less rewarding, and
has been linked with sickness absence in previous
studies.5 6 9 13 19 35 38–40 On the other hand, job insecurity would
be expected to act as a disincentive to sickness absence, and has
been associated with lower rates of absence in a previous study.41
Other factors showed associations with musculoskeletal absence
even in the model that included absence for non-musculoskeletal
illness. As well as prolonged absence for non-musculoskeletal
illness, these were the group prevalence of time pressure at work
(higher risk); adverse beliefs about the work-relatedness of muscu-
loskeletal pain (higher risk) and adverse beliefs about musculoskel-
etal pain and physical activity (lower risk). The relation to absence
for non-musculoskeletal illness is likely to be explained, at least in
part, by differences in absence culture.3 15 42 Similarly, if there is a
widespread belief among a workforce that occupational activities
are an important cause of musculoskeletal disorders, that could
create a culture in which workers are more aware of musculoskel-
etal symptoms, and more likely to withdraw from work when they
occur. Time pressures may render work especially difﬁcult when
musculoskeletal symptoms occur, and thereby increase absence.
More difﬁcult to explain is the inverse association with group
prevalence of adverse beliefs about physical activity. This was
apparent when the group level risk factors were analysed individu-
ally (Model 4), as well as when their effects were mutually adjusted
(Models 5 and 6), but was contrary to the ﬁndings from analysis
of individual risk factors, in which such beliefs carried a higher
risk. Despite its high statistical signiﬁcance, the association may
have occurred simply by chance.
By contrast with ﬁndings from several earlier
studies,3 16 17 19 22 we found no indication that provision of
sick pay was associated with a higher frequency of absence for
musculoskeletal pain. This may be because our deﬁnition of pro-
longed absence which could have included some individuals
with repeated short episodes of absence, as well as those who
were absent for longer continuous periods, differed from the
outcome measures used in other investigations.
Our ﬁndings indicate that we have failed to capture all the
factors responsible for large differences between occupational
groups in the prevalence of prolonged sickness absence for
musculoskeletal pain (ﬁgure 2). Nevertheless, they suggest
several approaches by which employers might reduce sickness
absence from common musculoskeletal disorders. Care should
be taken not to overstate work as a cause of musculoskeletal
injury, since adverse beliefs about work-relatedness appear to be
associated with a higher risk of absence. Where possible, work
should be organised to reduce excessive time pressures, and to
allow greater ﬂexibility of activities for workers who have symp-
toms which make their normal job unusually difﬁcult. Also,
where there is a culture of absence, this might be reduced by
maximising the responsibility that is given to employees, and
the control which they have over their work. The impact of
such measures could usefully be investigated by intervention
studies.
What this paper adds
▸ Earlier studies have suggested substantial international
variation in rates of sickness absence, but their design has
not allowed detailed exploration of the reasons for the
observed differences.
▸ In our large international survey, personal risk factors for
prolonged musculoskeletal absence included older age,
lower educational level, tendency to somatise, physical
loading at work and prolonged absence for
non-musculoskeletal illness, but these explained little of the
>30-fold variation in prevalence between occupational
groups.
▸ After adjustment for individual characteristics, prolonged
musculoskeletal absence was more frequent in groups with
greater time pressure at work, lower job control and more
adverse beliefs about the work-relatedness of
musculoskeletal disorders.
▸ Our ﬁndings suggest that musculoskeletal sickness absence
might be reduced by eliminating excessive time pressures in
work, maximising employees’ responsibility and control, and
providing ﬂexibility of duties for those with disabling
symptoms, and the impact of such measures could usefully
be investigated by intervention studies.
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